Expert Review of Neurotherapeutics

Aims & Scope

Expert Review of Neurotherapeutics (ISSN 1473-7175) provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry.

Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer's and Parkinson's.

Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.4
2024	3.40

SJR (SCImago Journal Rank)

Year	Value
2024	1.162

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	103

Journal Rank

Year	Value
2024	3760

Journal Citation Indicator

Year	Value
2024	1112

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Neuroscience, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Pain catastrophizing: a critical review

  Citation: 1104

  Authors: Phillip J, Claudia M, Robert R

• Transition from acute to chronic postsurgical pain: risk factors and protective factors

  Citation: 602

  Authors: Joel, Ze’ev

• Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications

  Citation: 495

  Authors: Elliott J, Scott E, Sylvia E, Stephen D

• The intolerance of uncertainty construct in the context of anxiety disorders: theoretical and practical perspectives

  Citation: 460

  Authors: R Nicholas

• Internet-based psychological treatments for depression

  Citation: 424

  Authors: Robert, Gerhard

• Cyberchondria: towards a better understanding of excessive health-related Internet use

  Citation: 343

  Authors: Vladan, David

• Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer’s disease-type beta-amyloid neuropathological mechanisms

  Citation: 313

  Authors: Lap, Kenjiro, Mayumi, Paolo, Risham, Giulio M.

• Role of central dopamine in pain and analgesia

  Citation: 307

  Authors: Patrick B

• Gait training strategies to optimize walking ability in people with stroke: a synthesis of the evidence

  Citation: 304

  Authors: Janice J, Pei-Fang

• Distinguishing Alzheimer’s disease from other major forms of dementia

  Citation: 290

  Authors: Stella, James E

---